60 related articles for article (PubMed ID: 2116222)
21. CD40 ligand-CD40 interaction induces chemokines in cervical carcinoma cells in synergism with IFN-gamma.
Altenburg A; Baldus SE; Smola H; Pfister H; Hess S
J Immunol; 1999 Apr; 162(7):4140-7. PubMed ID: 10201939
[TBL] [Abstract][Full Text] [Related]
22. Identification of constitutive and gamma-interferon- and interleukin 4-regulated proteins in the human renal carcinoma cell line ACHN.
Sullivan CM; Smith DM; Matsui NM; Andrews LE; Clauser KR; Chapeaurouge A; Burlingame AL; Epstein LB
Cancer Res; 1997 Mar; 57(6):1137-43. PubMed ID: 9067284
[TBL] [Abstract][Full Text] [Related]
23. Interferon-alpha and all-trans-retinoic acid reversibly inhibit the in vitro proliferation of cell lines derived from cervical cancers.
Massad LS; Turyk ME; Bitterman P; Wilbanks GD
Gynecol Oncol; 1996 Mar; 60(3):428-34. PubMed ID: 8774652
[TBL] [Abstract][Full Text] [Related]
24. Transduction of human renal carcinoma cells with human gamma-interferon gene via retroviral vector.
Nayak SK; McCallister T; Han LJ; Gangavalli R; Barber J; Dillman RO
Cancer Gene Ther; 1996; 3(3):143-50. PubMed ID: 8725877
[TBL] [Abstract][Full Text] [Related]
25. Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma.
Freedman RS; Kudelka AP; Kavanagh JJ; Verschraegen C; Edwards CL; Nash M; Levy L; Atkinson EN; Zhang HZ; Melichar B; Patenia R; Templin S; Scott W; Platsoucas CD
Clin Cancer Res; 2000 Jun; 6(6):2268-78. PubMed ID: 10873077
[TBL] [Abstract][Full Text] [Related]
26. Induction of death (CD95/FAS), activation and adhesion (CD54) molecules on blast cells of acute myelogenous leukemias by TNF-alpha and IFN-gamma.
Munker R; Andreeff M
Cytokines Mol Ther; 1996 Sep; 2(3):147-59. PubMed ID: 9384699
[TBL] [Abstract][Full Text] [Related]
27. Interferon-alpha and interferon-gamma combined with chemotherapy: in vitro sensitivity studies in non-small cell lung cancer cell lines.
Hand A; Pelin K; Halme M; Ekman A; Mattson M; Vallas M; Mattson K; Linnainmaa K; Husgafvel-Pursiainen K
Anticancer Drugs; 1993 Jun; 4(3):365-8. PubMed ID: 8395259
[TBL] [Abstract][Full Text] [Related]
28. Mechanisms of combined effects of gamma-interferon and 5-fluorouracil on human colon cancers implanted into nude mice.
Morikawa K; Fan D; Denkins YM; Levin B; Gutterman JU; Walker SM; Fidler IJ
Cancer Res; 1989 Feb; 49(4):799-805. PubMed ID: 2492206
[TBL] [Abstract][Full Text] [Related]
29. Nitric oxide sensitizes ovarian tumor cells to Fas-induced apoptosis.
Garbán HJ; Bonavida B
Gynecol Oncol; 1999 May; 73(2):257-64. PubMed ID: 10329044
[TBL] [Abstract][Full Text] [Related]
30. Analysis of receptors, cell surface antigens, and proteins in human melanoma cell lines resistant to human recombinant beta- or gamma-interferon.
Gomi K; Akinaga S; Oka T; Morimoto M
Cancer Res; 1986 Dec; 46(12 Pt 1):6211-6. PubMed ID: 2430691
[TBL] [Abstract][Full Text] [Related]
31. Effects of human recombinant alpha 2 arg-interferon and gamma-interferon on human breast cancer cell lines: dissociation of antiproliferative activity and induction of HLA-DR antigen expression.
Gastl G; Marth C; Leiter E; Gattringer C; Mayer I; Daxenbichler G; Flener R; Huber C
Cancer Res; 1985 Jul; 45(7):2957-61. PubMed ID: 3924395
[TBL] [Abstract][Full Text] [Related]
32. Synergistic antiproliferative effects of human recombinant alpha 54- or beta ser-interferon with gamma-interferon on human cell lines of various histogenesis.
Schiller JH; Groveman DS; Schmid SM; Willson JK; Cummings KB; Borden EC
Cancer Res; 1986 Feb; 46(2):483-8. PubMed ID: 2416427
[TBL] [Abstract][Full Text] [Related]
33. Multiple roles of interferon-gamma in the mediation of interleukin 12-induced tumor regression.
Ogawa M; Yu WG; Umehara K; Iwasaki M; Wijesuriya R; Tsujimura T; Kubo T; Fujiwara H; Hamaoka T
Cancer Res; 1998 Jun; 58(11):2426-32. PubMed ID: 9622084
[TBL] [Abstract][Full Text] [Related]
34. Lytic susceptibility of target cells to cytotoxic T cells is determined by their constitutive major histocompatibility complex class I antigen expression and cytokine-induced activation status.
Ritter M; Huber C; Auböck J; Pohl-Markl H; Troppmair J; Herold M; Gächter A; Nussbaumer W; Böck G; Nachbaur D
Immunology; 1994 Apr; 81(4):569-77. PubMed ID: 7913694
[TBL] [Abstract][Full Text] [Related]
35. Cytotoxic response of ovarian cancer cell lines to IFN-gamma is associated with sustained induction of IRF-1 and p21 mRNA.
Burke F; Smith PD; Crompton MR; Upton C; Balkwill FR
Br J Cancer; 1999 Jun; 80(8):1236-44. PubMed ID: 10376977
[TBL] [Abstract][Full Text] [Related]
36. Differential regulation of carcinoembryonic antigen and biliary glycoprotein by gamma-interferon.
Takahashi H; Okai Y; Paxton RJ; Hefta LJ; Shively JE
Cancer Res; 1993 Apr; 53(7):1612-9. PubMed ID: 8453631
[TBL] [Abstract][Full Text] [Related]
37. Cytokine production by T-cell lines derived from tumor-infiltrating lymphocytes from patients with ovarian carcinoma: tumor-specific immune responses and inhibition of antigen-independent cytokine production by ovarian tumor cells.
Kooi S; Freedman RS; Rodriguez-Villanueva J; Platsoucas CD
Lymphokine Cytokine Res; 1993 Dec; 12(6):429-37. PubMed ID: 8123759
[TBL] [Abstract][Full Text] [Related]
38. Synergistic effects of IL-6 and IFN-gamma on carcinoembryonic antigen (CEA) and HLA expression by human colorectal carcinoma cells: role for endogenous IFN-beta.
Dansky-Ullmann C; Salgaller M; Adams S; Schlom J; Greiner JW
Cytokine; 1995 Feb; 7(2):118-29. PubMed ID: 7780031
[TBL] [Abstract][Full Text] [Related]
39. Proliferative and antiproliferative effects of interferon-gamma and tumor necrosis factor-alpha on cell lines derived from cervical and ovarian malignancies.
Mutch DG; Massad LS; Kao MS; Collins JL
Am J Obstet Gynecol; 1990 Dec; 163(6 Pt 1):1920-4. PubMed ID: 2124085
[TBL] [Abstract][Full Text] [Related]
40. Resistance to cytolysis by tumor necrosis factor alpha in malignant gynecological cell lines is associated with the expression of protein(s) that prevent the activation of phospholipase A2 by tumor necrosis factor alpha.
Mutch DG; Powell CB; Kao MS; Collins JL
Cancer Res; 1992 Feb; 52(4):866-72. PubMed ID: 1737348
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
